Palmoplantar pustular psoriasis: Successful therapy with efalizumab after non-response to infliximab

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 17, Issue 3, 2008, Pages 133-136

  Wozel, Gottfried G ^a   Vitéz, Lilla ^a   Meurer, Michael ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Efalizumab; Palmoplantar; Pustular psoriasis

Indexed keywords

ANTIPSORIASIS AGENT; BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; CALCIPOTRIOL; COAL TAR; CYCLOSPORIN; DOXYCYCLINE; EFALIZUMAB; ETRETIN; FUMADERM; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; MOMETASONE FUROATE; PREDNISOLONE; RETINOID DERIVATIVE; VITAMIN D DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLIMATOTHERAPY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LOW DRUG DOSE; MONOTHERAPY; PHOTOTHERAPY; PUSTULOSIS PALMOPLANTARIS; SKIN MANIFESTATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; PSORIASIS;

EID: 55049111147     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Weinstein GD, Menter MA. An overview of psoriasis. In: Weinstein GD, Gottlieb AB, editors. Therapy of moderate to severe psoriasis. 2nd ed. New York, Basel: Marcel Dekker; 2003. p. 1-28.
2. Wright S, Baker H. Localized pustular psoriasis. In: Roenigh HH, Maibach HI, editors. Psoriasis. New York, Basel: Marcel Dekker; 1985. p. 45-57.
3. Marsland AM, Chalmers RJG, Hollis S, Leonardi-Bee J, Griffiths CEM. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev. 2006; 25: CD001433.
4. Eriksson MO, Hagforsen E, Lundin PI, Michaelsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Brit J Dermatol. 1998;138:390-8.
5. O'Doherty CJ, Macintyre C. Palmoplantar pustulosis and smoking. Brit Med J. 1985;291:861-4.
6. Hellgren L, Mobacken H. Pustulosis palmoplantaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol. 1971;51:284-8.
7. Sterry W, Barker J, Boehncke WH et al. Biological therapies in the systemic management of psoriasis: International consensus conference. Brit J Dermatol. 2004;151 (suppl.):3-17.
8. Wozel G. Clinical review: Biological agents in the treatment of psoriasis. Hosp Pharm Eur. 2005;23:59-61.
9. Hagforsen E, Awder M, Lefvert AK et al. Palmoplantar pustulosis: an autoimmune disease precipitated by smoking? Acta Derm Venereol. 2002;82:341-6.
10. Hagforsen E, Edvinsson M, Nordlind K, Michaelsson G. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Brit J Dermatol. 2002;146:383-91.
11. Christophers E. Targeting T-cell subsets to achieve remission. J Eur Acad Dermatol Venereol. 2003;17 (suppl.):6-11.
12. Gottlieb AB, Hamilton T, Caro I et al. Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial. J Am Acad Dermatol. 2006;54:154-63.
13. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CEM. Infliximab induction and maintenance therapy for moderate to severe psoriasis: a phase III, multicentre, double-blind trial. Lancet. 2005;366:1367-74.
14. Schmick K, Grabbe J. Recalcitrant, generalized pustular psoriasis: rapid and lasting therapeutic response to antitumor necrosis factor alpha antibody (infliximab). Brit J Dermatol. 2004;150:367.
15. Newland MR, Weinstein A, Kerdel F. Rapid response to Infliximab in severe pustular psoriasis, von Zumbusch type. Int J Dermatol. 2002;41:449-52.
16. Yeung-Yue K, Aronson PJ, Murakawa GJ. Clinical improvement of palmoplantar pustular psoriasis with alefacept. J Am Acad Dermatol. 2005;Suppl. 3:52:P 2730.
17. Fretzin SA, Dawes KW. Efficacy and safety of efalizumab for patients with palmoplantar pustulosis. J Am Acad Dermatol. 2005;52;Suppl. 3:P2745.
18. Sobell J, Fretzin S. Case studies of efalizumab in hand and foot psoriasis. J Am Acad Dermatol. 2006;54;Suppl. 3:P2864.